Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

BACKGROUND: Osteoprotegerin (OPG) is a tumour and/or bone derived factor that may protect tumour cells from apoptosis. In this study, we have measured serum OPG levels in untreated prostate cancer patients with advanced prostate cancer compared to patients with organ confined disease and in treated...

Полное описание

Библиографические подробности
Главные авторы:	Eaton, C, Wells, J, Holen, I, Croucher, P, Hamdy, F
Формат:	Journal article
Язык:	English
Опубликовано:	2004

Схожие документы

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
по: Eaton, C, и др.
Опубликовано: (2004)

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
по: Holen, I, и др.
Опубликовано: (2002)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
по: Holen, I, и др.
Опубликовано: (2002)

Role of osteoprotegerin (OPG) in cancer.
по: Holen, I, и др.
Опубликовано: (2006)

The role of osteoprotegerin in breast and prostate cancer
по: Holen, I, и др.
Опубликовано: (2002)

OPG is a survival factor for breast- and prostate cancer cells in vitro
по: Holen, I, и др.
Опубликовано: (2002)

Polymorphisms within the osteoprotegerin (OPG) gene are associated with both serum OPG levels and bone mineral density.
по: Miles, L, и др.
Опубликовано: (2004)

Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome
по: Gamal B Mohamed, и др.
Опубликовано: (2011-01-01)

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
по: Holen Ingunn, и др.
Опубликовано: (2009-07-01)

Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis
по: Lili Zhang, и др.
Опубликовано: (2016-11-01)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
по: Riham Eid, и др.
Опубликовано: (2023-06-01)

Significant Inverse Correlation of Serum Levels of Osteoprotegerin (OPG) and Transferrin Saturation in Thalassemia Dependent Transfusion (TDT) Patients
по: Indra Wijaya, и др.
Опубликовано: (2024-01-01)

Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
по: Croucher, P, и др.
Опубликовано: (2000)

Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females
по: Saba Tariq, и др.
Опубликовано: (2022-02-01)

Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?
по: Shipman, C, и др.
Опубликовано: (2002)

Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
по: Siamak Kazemi-Sufi, и др.
Опубликовано: (2024-09-01)

Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.
по: Shipman, C, и др.
Опубликовано: (2000)

Osteoprotegerin (OPG) is a soluble decoy receptor for TRAIL/Apo2L and can inhibit TRAIL/Apo2L-induced apoptosis of human myeloma cells in vitro.
по: Shipman, C, и др.
Опубликовано: (2002)

Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
по: Noura N. Alraouji, и др.
Опубликовано: (2024-08-01)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
по: Chan Kai-Ming, и др.
Опубликовано: (2011-07-01)

Osteoprotegerin (OPG): A potential biomarker for adverse cardiovascular events in stable coronary artery disease
по: Syed Muhammad Muneeb Akhtar, и др.
Опубликовано: (2024-07-01)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
по: Waterman, E, и др.
Опубликовано: (2007)

Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis
по: Alice Wang, и др.
Опубликовано: (2021-07-01)

Analysis of periodontal parameteres and salivary levels of Receptor Activator of NF- κβ Ligand (RANKL) and Osteoprotegerin (OPG) in obese periodontitis patients
по: Cheema, Raheem Ramzan
Опубликовано: (2021)

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
по: Yao Jing, и др.
Опубликовано: (2011-03-01)

Changes of serum osteoprotegerin level in recurrent urolithiasis
по: A. V. Savilov, и др.
Опубликовано: (2023-10-01)

Can androgen receptor levels in the prostate predict non-organ-confined prostate cancer?
по: Hamdy, F
Опубликовано: (2005)

Osteoprotegerin and the development of myeloma bone disease
по: Croucher, P, и др.
Опубликовано: (2004)

Dickkopf-1 levels and serum Osteoprotegerin in women with Osteoporosis
по: Mehrzad Hajialilo, и др.
Опубликовано: (2013-12-01)

Serum levels of OPG, RANKL and RANKL/OPG ratios in newly-diagnosed patients with multiple myeloma. Clinical correlations
по: Veselina Goranova-Marinova, и др.
Опубликовано: (2007-07-01)

Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
по: Martin Widschwendter, и др.
Опубликовано: (2015-10-01)

Enhancing androgen ablation response in metastatic hormone-sensitive prostate cancer: the benefits of transurethral resection of the prostate
по: Yan Zhao, и др.
Опубликовано: (2023-07-01)

Rapid Androgen-Responsive Proteome Is Involved in Prostate Cancer Progression
по: Jong-Kwang Kim, и др.
Опубликовано: (2021-12-01)

The influence of vitamin D administration on the clinical presentation, body mass index, and osteoprotegerin (OPG) level in a sample of Egyptian children with familial Mediterranean fever
по: Hanaa Reyad Abdallah, и др.
Опубликовано: (2021-12-01)

Osteoprotegerin, sclerostin, and osteocalcin serum levels in thyroid disorder patients
по: F. F. Rija, и др.
Опубликовано: (2021-10-01)

Serum Osteoprotegerin Levels and the Vascular Reactivity Index in Patients with Hypertension
по: Yen-Liang Chen, и др.
Опубликовано: (2023-10-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
по: Yosra Azizpour, и др.
Опубликовано: (2020-01-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
по: Yosra Azizpour, и др.
Опубликовано: (2020-01-01)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
по: Croucher, P, и др.
Опубликовано: (2003)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
по: Croucher, P, и др.
Опубликовано: (2001)